SMSophie Matis

Sophie Matis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sophie Matis has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cognitive-linguistic skills in production of expository discourse: Insights from longitudinal changes and neural correlates in primary progressive aphasia

    by Marina A. Anwia, Mara Steinberg Lowe, Sophie Matis, James Carrick, Olivier Piguet, Ramon Landin-Romero, Kirrie J. Ballard


  • Open Access

    Amygdala subregional functional connectivity in treatment-resistant depression

    by Sheryl L. Foster, Ramon Landin-Romero, Sarah Lewis, Ana Rita Barreiros, Sophie Matis, Anthony Harris, Mayuresh S. Korgaonkar


  • Open Access

    Reduced plasma hexosylceramides in frontotemporal dementia are a biomarker of white matter integrity

    by Oana C. Marian, Sophie Matis, Carol Dobson-Stone, Woojin S. Kim, John B. Kwok, Olivier Piguet, Glenda M. Halliday, Ramon Landin-Romero, Anthony S. Don

    INTRODUCTION: Blood biomarkers are needed to facilitate new therapeutic trials and improve management of behavioural variant frontotemporal dementia (bvFTD). Since altered white matter integrity is characteristic of bvFTD, this study aimed to determine if plasma levels of myelin-enriched glycolipids are altered in bvFTD and correlate with white matter integrity. METHODS: Nineteen glycolipids were quantified in bvFTD (n=31) and control (n=26) plasma samples. White matter integrity was assessed using MRI-derived fibre tract density and cross-section (FDC). RESULTS: Eleven lipids were significantly lower in bvFTD compared to control subjects, seven were inversely correlated with disease duration, and twelve were positively correlated with cognitive performance, with C22:0 hexosylceramide most strongly correlated. FDC was lower in frontotemporal white matter tracts of bvFTD compared to control subjects, and plasma C22:0 hexosylceramide was significantly correlated with FDC in these tracts. DISCUSSION: Circulating glycolipids may be a valuable biomarker of myelin integrity and disease progression in FTD.

  • Open Access

    Amygdala subregional functional connectivity in Treatment-Resistant Depression

    by Sheryl L. Foster, Ramon Landin-Romero, Sarah Lewis, Ana Rita Barreiros, Sophie Matis, Anthony Harris, Mayuresh S. Korgaonkar

    Background: Treatment resistance impacts almost 50% of depression patients, with amygdala dysfunction being widely implicated. The amygdala is a complex amalgamation of subnuclei with diverse functions but fMRI studies have typically focussed on identifying whole rather than subregional amygdala functional connectivity. This study used high resolution 3T fMRI data to investigate subregional alterations that may differentiate treatment-resistant cohorts from healthy individuals and depressed patients who respond to treatment. Methods: Resting-state fMRI data were obtained in 35 participants diagnosed with Treatment-Resistant Depression (TRD), 38 healthy control participants (HC), and 35 treatment-sensitive participants (TSD). Seed-based functional connectivity analyses of the three main subregions bilaterally (laterobasal, centromedial and superficial), as well as the whole amygdala, were performed and comparisons made between groups. Results: We found c onnectivity differences in the right laterobasal amygdala subregion in TRD compared to both groups. TRD patients displayed hypoconnectivity to the right fusiform gyrus relative to HC whereas hyperconnectivity to the left inferior frontal gyrus relative to TSD was identified. No connectivity differences were found for the whole amygdala or any of the other subregions bilaterally. Limitations: Modest sample size and cross-sectional study design are limitations. A causal relationship between functional connectivity alterations and treatment resistance cannot be established. Conclusion: Altered connectivity of the right laterobasal subregion is a distinguishing feature of TRD. These alterations may underlie severe impairments in emotion processing and social functioning that are characteristic of TRD. These results emphasise the need for further investigation of the functional role of the amygdala subregions in depression.